Skip to main content

Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Edwards Lifesciences Corporation (NYSE: EW) today announced its chief financial officer, Scott Ullem, is scheduled to present at two upcoming conferences:

  • Tuesday, March 10, 2026 at 10:00 a.m. ET at the Barclays 28th Annual Global Healthcare Conference
  • Wednesday, March 11, 2026 at 10:00 a.m. ET at the Leerink Global Healthcare Conference

A live webcast of each presentation will be available on the Edwards investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.19
+0.69 (0.28%)
AAPL  263.44
-2.99 (-1.12%)
AMD  275.95
+17.83 (6.91%)
BAC  53.67
-0.65 (-1.19%)
GOOG  333.37
-1.10 (-0.33%)
META  675.19
+3.61 (0.54%)
MSFT  419.31
+8.08 (1.97%)
NVDA  198.35
-0.52 (-0.26%)
ORCL  177.94
+8.13 (4.79%)
TSLA  388.01
-3.94 (-1.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.